Eser, B. Et Al. 2006. Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. AMERICAN JOURNAL OF HEMATOLOGY , vol.81, no.5 , 307-314.

Eser, B., Sarı, İ., Canoz, Z., Altuntaş, F., çakmak, E., Ozturk, A., ... Ozkan, M.(2006). Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma. AMERICAN JOURNAL OF HEMATOLOGY , vol.81, no.5, 307-314.

Eser, BÜLENT Et Al. "Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma," AMERICAN JOURNAL OF HEMATOLOGY , vol.81, no.5, 307-314, 2006

Eser, BÜLENT Et Al. "Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma." AMERICAN JOURNAL OF HEMATOLOGY , vol.81, no.5, pp.307-314, 2006

Eser, B. Et Al. (2006) . "Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma." AMERICAN JOURNAL OF HEMATOLOGY , vol.81, no.5, pp.307-314.

@article{article, author={BÜLENT ESER Et Al. }, title={Prognostic significance of Fas (CD95/APO-1) positivity in patients with primary nodal diffuse large B-cell lymphoma}, journal={AMERICAN JOURNAL OF HEMATOLOGY}, year=2006, pages={307-314} }